LESOFAVUMAB

UNII:	J8O0SI025W
Formula:
Preferred Substance Name:	LESOFAVUMAB

1807960-57-1
IMMUNOGLOBULIN G1, ANTI-(INFLUENZA B VIRUS VIRAL HEMAGGLUTININ) (HUMAN MONOCLONAL MHAB5553A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MHAB5553A LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-( INFLUENZA B VIRUS HEMAGGLUTININ)HOMO SAPIENS MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-453) (HOMO SAPIENS VH (IGHV5-51*01 (90%) (IGHD)-IGHJ5*01 (93%)) (8.8.16) (1-123) -HOMO SAPIENS IGHG1*03 (CH1(R97>K(220)) (124-453)) (226-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HOMO SAPIENS V-KAPPA (IGKV2-28*01 (99%) IGKJ2*01) (11.3.9) (1'-112') -HOMO SAPIENS IGKC*01 (113'-219'))DIMER (232-232'':235-235'')-BISDISULFIDE
LESOFAVUMAB [INN]
LESOFAVUMAB [USAN]
MHAB5553A
RG70026
RO7045557

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LESOFAVUMAB

Synonyms and Mappings

Resources